Multiple Myeloma
📧 Sign up to get email alerts when something new happens for Multiple Myeloma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2017-05-30Clinical Trial Update: Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other Diseases [NA]
This ClinicalTrials.gov update reports on a completed study evaluating whether music can reduce anxiety and pain in adults undergoing bone m…
-
CLINICAL_TRIALS trial_result · 2017-05-25Clinical Trial Update: XL184 For Relapsed/Refractory Multiple Myeloma (MM) With Bone Disease [Phase 1]
Phase 1 trial of XL184 (cabozantinib) for relapsed/refractory multiple myeloma with bone disease has completed. The update indicates the stu…
-
CLINICAL_TRIALS trial_result · 2017-05-24Clinical Trial Update: Bendamustine Hydrochloride, Etoposide, Dexamethasone, and Filgrastim For Peripheral Blood Stem Cell Mobilization in Treating Patients With Refractory or Recurrent Lymphoma or Multiple Myeloma [Phase 2]
Phase 2 study evaluating the combination of bendamustine hydrochloride, etoposide, dexamethasone, and filgrastim for peripheral blood stem c…
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Pomalidomide in Combination With High Dose Dexamethasone and Oral Cyclophosphamide [Phase 1, Phase 2]
A completed Phase 1/2 trial evaluated pomalidomide with high-dose dexamethasone and oral cyclophosphamide in multiple myeloma; results were …
-
CLINICAL_TRIALS trial_result · 2017-05-23Clinical Trial Update: Busulfan in Multiple Myeloma [Phase 1]
The Phase 1 clinical trial of busulfan in multiple myeloma has been terminated.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-05-19Clinical Trial Update: Cyclophosphamide for Prevention of Graft-Versus-Host Disease After Allogeneic Peripheral Blood Stem Cell Transplantation in Patients With Hematological Malignancies [Phase 2]
Phase 2 study evaluating cyclophosphamide as GVHD prophylaxis after allogeneic peripheral blood stem cell transplantation in patients with h…
-
CLINICAL_TRIALS research · 2017-05-19Clinical Trial Update: Study of DNA Samples From Patients With Multiple Myeloma
An update on a study collecting DNA samples from patients with multiple myeloma, noting that the study status is completed.
-
CLINICAL_TRIALS trial_result · 2017-05-18Clinical Trial Update: Autologous or Syngeneic Stem Cell Transplant Followed by Donor Stem Cell Transplant and Bortezomib in Treating Patients With Newly Diagnosed High-Risk, Relapsed, or Refractory Multiple Myeloma [Phase 2]
Phase 2 trial evaluating autologous/syngeneic stem cell transplant followed by donor stem cell transplant with bortezomib in newly diagnosed…
-
CLINICAL_TRIALS research · 2017-05-17Clinical Trial Update: Studying Blood Samples From Patients With Multiple Myeloma Who Were Treated With Thalidomide or Lenalidomide
This update reports on a completed clinical study examining blood samples from patients with multiple myeloma and plasma cell neoplasms who …
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Melphalan, Peripheral Stem Cell Transplantation, and Interleukin-2 Followed by Interferon Alfa in Treating Patients With Advanced Multiple Myeloma [Phase 2]
A Phase 2 trial evaluating melphalan with peripheral stem cell transplantation followed by interleukin-2 and interferon alfa in patients wit…
-
CLINICAL_TRIALS trial_result · 2017-05-16Clinical Trial Update: Carfilzomib, Lenalidomide, and Dexamethasone in New Multiple Myeloma Patients [Phase 2]
Phase 2 clinical trial evaluating carfilzomib, lenalidomide, and dexamethasone in newly diagnosed multiple myeloma; study completed with pos…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Velcade®-Melphalan Association in Autologous Stem-Cell Transplantation (ASCT) [Phase 2]
A Phase 2 trial evaluating the combination of Velcade (bortezomib) with melphalan in autologous stem-cell transplantation for multiple myelo…
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Frontline Therapy in de Novo Multiple Myeloma Patients Under 65 [Phase 2]
A Phase 2 frontline therapy study for de novo multiple myeloma patients under 65 has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-12Clinical Trial Update: Lenalidomide Maintenance Therapy for Multiple Myeloma [Phase 2]
Phase 2 clinical trial update on lenalidomide maintenance therapy for multiple myeloma; the study status is terminated with results posted i…
-
FDA approval · 2017-05-11FDA Approved: EMPLICITI — Supplemental Application (E.R. Squibb & Sons, L.L.C.)
FDA approved a supplemental application for EMPLICITI (elotuzumab) submitted by E.R. Squibb & Sons, L.L.C.
-
CLINICAL_TRIALS trial_result · 2017-05-11Clinical Trial Update: Effects of Anticoagulant Preventive Injection in Patients With Blood Cancer [Phase 2]
Phase 2 clinical trial evaluating an anticoagulant preventive injection in patients with lymphoma or multiple myeloma has completed.
-
CLINICAL_TRIALS trial_result · 2017-05-10Clinical Trial Update: Diagnostic Imaging of Myeloma Bone Lesions [NA]
A completed clinical trial studying diagnostic imaging for bone lesions in multiple myeloma.
-
CLINICAL_TRIALS research · 2017-05-09Clinical Trial Update: Blood Samples From Patients on a Clinical Trial to CINV During HSCT
This is an update on a clinical trial involving collection of blood samples from patients undergoing chemotherapy-induced nausea and vomitin…
-
CLINICAL_TRIALS trial_result · 2017-05-09Clinical Trial Update: Pilot Study of Lymphoid Tumor Microenvironmental Dysruption Prior to Autologous Stem Cell Transplantation [Phase 1]
A Phase 1 pilot study evaluating disruption of the lymphoid tumor microenvironment prior to autologous stem cell transplantation was termina…
-
CLINICAL_TRIALS trial_result · 2017-05-04Clinical Trial Update: Non-Myeloablative Allogeneic HSCT From HLA Matched Related or Unrelated Donors for the Treatment of Low Grade B Cell Malignancies [Phase 2, Phase 3]
A phase 2/3 trial evaluating non-myeloablative allogeneic HSCT from HLA-matched related or unrelated donors in low-grade B-cell malignancies…
-
CLINICAL_TRIALS trial_result · 2017-05-03Clinical Trial Update: Plerixafor and Sargramostim (GM-CSF) for Mobilization of Allogeneic Sibling Donors [Phase 2]
Phase 2 clinical trial evaluating the combination of plerixafor and GM-CSF (sargramostim) for mobilizing hematopoietic stem cells from allog…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: A Study of Oprozomib, Melphalan, and Prednisone in Transplant Ineligible Patients With Newly Diagnosed Multiple Myeloma [Phase 1, Phase 2]
A Phase 1/Phase 2 trial evaluating Oprozomib in combination with Melphalan and Prednisone in transplant-ineligible patients with newly diagn…
-
CLINICAL_TRIALS trial_result · 2017-05-02Clinical Trial Update: Clinical Activity of Metformin With High-dose of Dexamethasone in Relapse Multiple Myeloma [Phase 2]
This entry reports a Phase 2 clinical trial evaluating the combination of metformin with high-dose dexamethasone in relapsed multiple myelom…
-
CLINICAL_TRIALS research · 2017-05-02Clinical Trial Update: Carfilzomib Multiple Myeloma Expanded Access Protocol for Patients With Relapsed and Refractory Disease
Amgen's expanded access protocol for carfilzomib in relapsed and refractory multiple myeloma has been updated, with the drug noted as approv…
-
CLINICAL_TRIALS trial_result · 2017-05-01Clinical Trial Update: A Study Evaluating Efficacy, Toxicity, Harvest Yield and Quality of Life [Phase 2]
This document reports the results of a Phase 2 clinical trial evaluating efficacy, toxicity, harvest yield, and quality of life in patients …